Insight Molecular Diagnostics (IMDX) Free Cash Flow Growth (1y) (2016 - 2026)
Insight Molecular Diagnostics (IMDX) Free Cash Flow Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 51.58% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 16.06% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -173.96% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 87.85% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 23.29% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 112.68% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -21.08% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 33.01% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -42.16% |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 | -54.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -54.02% |
| Mar 31, 2026 | -34.27% |
| Dec 31, 2025 | -26.22% |
| Sep 30, 2025 | -1.05% |
| Jun 30, 2025 | -5.74% |
| Mar 31, 2025 | -59.47% |
| Dec 31, 2024 | -18.71% |
| Sep 30, 2024 | -75.26% |
| Jun 30, 2024 | 9.70% |
| Mar 31, 2024 | 53.57% |
| Dec 31, 2023 | 55.14% |
| Sep 30, 2023 | 73.85% |
| Jun 30, 2023 | 44.75% |
| Mar 31, 2023 | 44.06% |
| Dec 31, 2022 | -39.97% |
| Sep 30, 2022 | -7.72% |
| Jun 30, 2022 | -42.65% |
| Mar 31, 2022 | -38.97% |
| Dec 31, 2021 | -18.32% |
| Sep 30, 2021 | -74.20% |